Log In
Print
BCIQ
Print
Print this Print this
 

Caelyx, Doxil, doxorubicin

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionLiposomal doxorubicin
Molecular Target DNA
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today